Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cosford

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Journal of Medicinal Chemistry|September 22, 2020
Identification and Development of a New Positron Emission Tomography Ligand 4-(2-Fluoro-4-[<sup>11</sup>C]methoxyphenyl)-5-((1-methyl-1<i>H</i>-pyrazol-3-yl)methoxy)picolinamide for Imaging Metabotropic Glutamate Receptor Subtype 2 (mGlu<sub>2</sub>)Tomoteru Yamasaki, Xiaofei Zhang, Katsushi Kumata, et al.
SLAS Discovery : Advancing Life Sciences R & D|October 9, 2022
Development and use of a high-throughput screen to identify novel modulators of the corticotropin releasing factor binding proteinCarolina L Haass-Koffler, T Chase Francis, Pauravi Gandhi, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
Development of a novel, CNS-penetrant, metabotropic glutamate receptor 3 (mGlu3) NAM probe (ML289) derived from a closely related mGlu5 PAMDouglas J Sheffler, Cody J Wenthur, Joshua A Bruner, et al.
Synapse (New York, N.Y.)|April 2, 2005
Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracersTerence G Hamill, Stephen Krause, Christine Ryan, et al.
ACS Chemical Biology|November 11, 2011
Inhibition of hematopoietic protein tyrosine phosphatase augments and prolongs ERK1/2 and p38 activationEduard Sergienko, Jian Xu, Wallace H Liu, et al.
Theranostics|October 12, 2020
Synthesis and preliminary studies of <sup>11</sup>C-labeled tetrahydro-1,7-naphthyridine-2-carboxamides for PET imaging of metabotropic glutamate receptor 2Xiaofei Zhang, Yiding Zhang, Zhen Chen, et al.
Cell Host & Microbe|September 11, 2015
BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral LatencyLars Pache, Miriam S Dutra, Adam M Spivak, et al.
The Journal of Biological Chemistry|December 13, 2021
Discovery of novel furanylbenzamide inhibitors that target oncogenic tyrosine phosphatase SHP2 in leukemia cellsDhanya Raveendra-Panickar, Darren Finlay, Fabiana Izidro Layng, et al.
Cancer Letters|March 11, 2022
Novel potent azetidine-based compounds irreversibly inhibit Stat3 activation and induce antitumor response against human breast tumor growth in vivoPeibin Yue, Yinsong Zhu, Christine Brotherton-Pleiss, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Synthesis and Characterization of ULK1/2 Kinase Inhibitors that Inhibit Autophagy and Upregulate Expression of Major Histocompatibility Complex I for the Treatment of Non-Small Cell Lung CancerFabiana Izidro A L Layng, Huiyu Ren, Nicole A Bakas, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Journal of Medicinal Chemistry|September 22, 2020
Identification and Development of a New Positron Emission Tomography Ligand 4-(2-Fluoro-4-[<sup>11</sup>C]methoxyphenyl)-5-((1-methyl-1<i>H</i>-pyrazol-3-yl)methoxy)picolinamide for Imaging Metabotropic Glutamate Receptor Subtype 2 (mGlu<sub>2</sub>)Tomoteru Yamasaki, Xiaofei Zhang, Katsushi Kumata, et al.
SLAS Discovery : Advancing Life Sciences R & D|October 9, 2022
Development and use of a high-throughput screen to identify novel modulators of the corticotropin releasing factor binding proteinCarolina L Haass-Koffler, T Chase Francis, Pauravi Gandhi, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
Development of a novel, CNS-penetrant, metabotropic glutamate receptor 3 (mGlu3) NAM probe (ML289) derived from a closely related mGlu5 PAMDouglas J Sheffler, Cody J Wenthur, Joshua A Bruner, et al.
Synapse (New York, N.Y.)|April 2, 2005
Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracersTerence G Hamill, Stephen Krause, Christine Ryan, et al.
ACS Chemical Biology|November 11, 2011
Inhibition of hematopoietic protein tyrosine phosphatase augments and prolongs ERK1/2 and p38 activationEduard Sergienko, Jian Xu, Wallace H Liu, et al.
Theranostics|October 12, 2020
Synthesis and preliminary studies of <sup>11</sup>C-labeled tetrahydro-1,7-naphthyridine-2-carboxamides for PET imaging of metabotropic glutamate receptor 2Xiaofei Zhang, Yiding Zhang, Zhen Chen, et al.
Cell Host & Microbe|September 11, 2015
BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral LatencyLars Pache, Miriam S Dutra, Adam M Spivak, et al.
The Journal of Biological Chemistry|December 13, 2021
Discovery of novel furanylbenzamide inhibitors that target oncogenic tyrosine phosphatase SHP2 in leukemia cellsDhanya Raveendra-Panickar, Darren Finlay, Fabiana Izidro Layng, et al.
Cancer Letters|March 11, 2022
Novel potent azetidine-based compounds irreversibly inhibit Stat3 activation and induce antitumor response against human breast tumor growth in vivoPeibin Yue, Yinsong Zhu, Christine Brotherton-Pleiss, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Synthesis and Characterization of ULK1/2 Kinase Inhibitors that Inhibit Autophagy and Upregulate Expression of Major Histocompatibility Complex I for the Treatment of Non-Small Cell Lung CancerFabiana Izidro A L Layng, Huiyu Ren, Nicole A Bakas, et al.
Pageof 11